Method of reducing the risk of retinopathy of prematurity in preterm infants
OwnerBridget Barrett-Reisinventor
Life of this patent
Estimating the term…
Abstract
Disclosed is a method of reducing the risk or severity of retinopathy of prematurity in preterm infants. The method comprises (a) measuring skin carotenoid levels in preterm infants, preferably by Raman Spectroscopy, and then (b) administering supplemental carotenoids to those infants in need thereof, wherein the supplemental carotenoids comprise lutein, lycopene, beta-carotene, and zeaxanthin. The supplemental carotenoids may be provided by an infant formula comprising, on a ready-to-feed basis, from about 100 to about 2000 mcg/liter of total carotenoids, wherein the total carotenoids include at least about 50 mcg/liter of lutein. The formulas may further comprise docosahexaenoic acid.
Claims12
A method of reducing the risk or severity of retinopathy of prematurity in preterm infants, said method comprising:
- (a) measuring skin carotenoid levels in preterm infants, and then
- (b) administering supplemental carotenoids to those infants in need thereof, wherein the supplemental carotenoids comprise lutein, lycopene, beta carotene, and zeaxanthin.
Dependencies are inferred from the claim text.